Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel H Ahn
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Toledo Clinic Cancer Center
Toledo, Ohio, United States
- Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Aurora Cancer Care-Milwaukee West
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Mar 2020
- Primary completion
- 5 Sept 2023
- Completion
- 31 Mar 2025
- Last update posted
- 27 Sept 2024
- Registered enrollment
- 22
- Registry id
- NCT04117945
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.